Ameriprise’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-227,635
| Closed | -$9.64M | – | 3965 |
|
2024
Q1 | $9.64M | Sell |
227,635
-79,590
| -26% | -$3.37M | ﹤0.01% | 1820 |
|
2023
Q4 | $12.8M | Buy |
307,225
+2,916
| +1% | +$122K | ﹤0.01% | 1582 |
|
2023
Q3 | $11.5M | Buy |
304,309
+74,054
| +32% | +$2.79M | ﹤0.01% | 1585 |
|
2023
Q2 | $8.73M | Buy |
230,255
+23,292
| +11% | +$883K | ﹤0.01% | 1888 |
|
2023
Q1 | $5.03M | Sell |
206,963
-72,070
| -26% | -$1.75M | ﹤0.01% | 2317 |
|
2022
Q4 | $8.1M | Buy |
279,033
+95,893
| +52% | +$2.78M | ﹤0.01% | 1920 |
|
2022
Q3 | $5.49M | Buy |
183,140
+25,865
| +16% | +$775K | ﹤0.01% | 2147 |
|
2022
Q2 | $5.69M | Sell |
157,275
-65,568
| -29% | -$2.37M | ﹤0.01% | 2183 |
|
2022
Q1 | $9.64M | Buy |
222,843
+71,489
| +47% | +$3.09M | ﹤0.01% | 1947 |
|
2021
Q4 | $7.59M | Sell |
151,354
-36,060
| -19% | -$1.81M | ﹤0.01% | 2184 |
|
2021
Q3 | $11.9M | Buy |
187,414
+3,568
| +2% | +$227K | ﹤0.01% | 1710 |
|
2021
Q2 | $13.2M | Buy |
183,846
+99,945
| +119% | +$7.19M | ﹤0.01% | 1688 |
|
2021
Q1 | $6.19M | Buy |
83,901
+1,736
| +2% | +$128K | ﹤0.01% | 2261 |
|
2020
Q4 | $6.03M | Buy |
82,165
+68,710
| +511% | +$5.05M | ﹤0.01% | 2138 |
|
2020
Q3 | $738K | Buy |
13,455
+1,380
| +11% | +$75.7K | ﹤0.01% | 3095 |
|
2020
Q2 | $803K | Sell |
12,075
-4,882
| -29% | -$325K | ﹤0.01% | 3012 |
|
2020
Q1 | $1.04M | Buy |
16,957
+1,500
| +10% | +$91.7K | ﹤0.01% | 2804 |
|
2019
Q4 | $1.36M | Buy |
15,457
+300
| +2% | +$26.4K | ﹤0.01% | 2928 |
|
2019
Q3 | $1.14M | Hold |
15,157
| – | – | ﹤0.01% | 2965 |
|
2019
Q2 | $1.3M | Buy |
15,157
+1,950
| +15% | +$167K | ﹤0.01% | 2958 |
|
2019
Q1 | $1.43M | Buy |
+13,207
| New | +$1.43M | ﹤0.01% | 2891 |
|
2014
Q4 | – | Sell |
-221
| Closed | -$34K | – | 4512 |
|
2014
Q3 | $34K | Buy |
+221
| New | +$34K | ﹤0.01% | 4180 |
|